Filters
reset all| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Molecular Genetics Laboratory London Health Sciences Centre Canada | 3 | 1 |
|
Hereditary Neuropathy with Liability to Pressure Palsies (PMP22) Molecular Genetics Laboratory London Health Sciences Centre Canada | 3 | 1 |
|
PMP22 Gene, Deletion/Duplication Mayo Clinic Laboratories Mayo Clinic United States | 2 | 1 |
|
High-Resolution Rapid Microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Molecular Genetics Laboratory London Health Sciences Centre Canada | 46 | 34 |
|
Rapid microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Peripheral myelin protein 22 (PMP22) gene dosage evaluation by MLPA analysis Neurogenetics Department Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 6 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Centogene AG - the Rare Disease Company Germany | 203 | 194 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae Comprehensive Deafness Panel Invitae United States | 405 | 219 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Charcot-Marie-Tooth disease Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 50 | 43 |
|
Charcot-Marie-Tooth disease Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 50 | 43 |
|
Charcot Marie Tooth disease, type 1A Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 1 | 1 |
|
Comprehensive Neuropathy Panel PreventionGenetics United States | 82 | 71 |
|
Invitae Comprehensive Neuropathies Panel Invitae United States | 201 | 96 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.